Clinical trial focusing on tumor tissue samples and malignant melanoma. Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
Clinical trial focusing on intraturmoral interferon gamma and peptide based vaccine. Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With Melanoma (Mel 51)
Clinical trial focusing on families with melanoma. Study of Families With Melanoma
Clinical Trial: Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery Sponsor and CollaboratorsNational Cancer Institute (NCI) Principal InvestigatorRoxana Dronca, Mayo Clinic ClinicalTrials.gov IdentifierNCT01328535Continue Reading
A look at the following clinical trial: Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma
A look at the following clinical trial: Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells
A look at the following clinical trial: Characterisation of T Lymphocytes, NK Cells and Macrophages in Melanoma Patients
A look at the following clinical trial: Efficacy of Nilotinib in First or Second Line Treatment of Primary Melanomas Stage III Unresectable Melanomas.
A look at the following clinical trial: Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes
A look at the following clinical trial: Melanoma Risk-Reduction Among Patients and Family Members
Please login or register first to view this content.
